Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tribune.
Press releases published on September 4, 2025

BTR: AI‑Fueled DDoS Attacks Raise Stakes for Mid‑Market Manufacturers and Industrial Operators
SILVER SPRING, MD, UNITED STATES, September 4, 2025 /EINPresswire.com/ -- The rise of artificial intelligence is transforming the nature of distributed denial‑of‑service (DDoS) attacks, creating a new level of urgency for mid‑market manufacturers and …

New research-based platform empowers religious judicatories to measure and enhance congregational vitality
Religious groups now have access to a digital platform designed to help them measure and improve the vitality and sustainability of their congregations. LUTHERVILLE, MD, UNITED STATES, September 4, 2025 /EINPresswire.com/ -- The Congregational Vitality …

Inteleos Partners with ITS to Launch Modernized ABVM Maintenance of Certification Program
BALTIMORE, MD, UNITED STATES, September 4, 2025 /EINPresswire.com/ -- ITS, a leader in online test delivery and AI-powered assessment solutions, has partnered with Inteleos, a global non-profit dedicated to elevating the standard of global healthcare, to …

Nominations Now Open for the 2026 Cybersecurity Excellence Awards
Honoring the leaders and innovations redefining cybersecurity and digital trust in the age of AI. BALTIMORE, MD, UNITED STATES, September 4, 2025 /EINPresswire.com/ -- Nominations are now open for the 2026 Cybersecurity Excellence Awards, the premier …

Service Coordination, Inc. President & CEO John Dumas Named One of Maryland’s 2025 Most Admired CEOs
Frederick, MD, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Daily Record has named John Dumas, President …

Rise of Weed Pollen and Return to School Ushers in Sneezing Season
Washington, DC, Sept. 04, 2025 (GLOBE NEWSWIRE) -- If you’re sneezing this season, the reason could be a respiratory infection or weed pollen allergy. A review of pollen counts from cities across the country reveals a rise in levels of ragweed pollen as …

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ …

Rise of Weed Pollen and Return to School Ushers in Sneezing Season
Washington, DC, Sept. 04, 2025 (GLOBE NEWSWIRE) -- If you’re sneezing this season, the reason could be a respiratory infection or weed pollen allergy. A review of pollen counts from cities across the country reveals a rise in levels of ragweed pollen as …

Interview Warns: Three Popular U.S. Companies Could Collapse Under Trump’s Next Move
Baltimore, MD, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Jim Rickards suggests that while some companies stand to benefit from Trump’s economic reset, others could face steep declines. Rickards, a former advisor to the CIA, Pentagon, and four U.S. Presidents, …

Forterra Selected to Support U.S. Army’s Plan to Integrate Autonomous Capabilities into Uncrewed Systems
Washington, D.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Forterra, the leading provider of autonomous mission systems for defense has been selected by the U.S. Army to support the agency’s plan to prove out autonomy for Uncrewed Systems (UxS). The Army seeks …

Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange
GAITHERSBURG, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it has been selected to exhibit the EluPro™ Antibiotic-Eluting BioEnvelope …

Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation
Ongoing Phase 1b trial of GT-02287 to be extended by an additional nine months for participants who enrolled in the original three-month study design The independent data monitoring committee (DMC) met recently and recommended to continue the study with no …

CorVista Health Announces Publication of Real-World Case Series in the Journal of the American College of Cardiology Exploring its Non-Invasive Test for Earlier Diagnosis of Pulmonary Hypertension
BETHESDA, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced the publication of a new case series in the Journal of the American College of Cardiology (JACC), showcasing real-world clinical applications of the CorVista System®, a novel …

NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference
BELTSVILLE, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced that it …